The stroke byproduct acrolein activates the precursor of heparanase, an enzyme that degrades the glycocalyx in the blood-brain barrier.
Acrolein, a molecule implicated as a metabolic waste product, could be a potential biomarker for multiple sclerosis, researchers report.
Acrolein, a toxic substance produced during oxidative stress, may play a role in preventing the process of fibrillation.
Findings suggest a possible new diagnostic tool for early detection and treatment of blast related TBI.
Acrolein, a toxin found in cigarette smoke can exacerbate pain and worsen symptoms of multiple sclerosis, a new study reports.
Researchers adapt a medical test, previously developed to measure a toxin found in smokers, to measure the same toxin in people suffering from MS and spinal cord injuries.
